Telo Genomics Corp (TELO)

Currency in CAD
0.0450
0.0000(0.00%)
Closed·
TELO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.04500.0450
52 wk Range
0.04000.1400
Key Statistics
Bid/Ask
0.04 / 0.045
Prev. Close
0.045
Open
0.045
Day's Range
0.045-0.045
52 wk Range
0.04-0.14
Volume
-
Average Volume (3m)
145.47K
1-Year Change
-70%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TELO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Telo Genomics Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

Telo Genomics Company Profile

Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada. The company’s TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive of genomic instability, identify specific disease mechanisms, predict disease risks, and determine effective treatments. Its lead product is TeloView-SMM (Smoldering Multiple Myeloma) for SMM patients with a high risk of transition to multiple myeloma (MM). The company also develops TeloView NDMM, which predicts newly diagnosed MM patients who may relapse on first-line therapy; TeloMRD-D, which identifies and enumerates MRD cells in post-transplant patients; and TeloViewNG-MRD (Minimal Residual Disease) Profiling for genomic instability profiling of MRD-detected cells in post-transplant patients. It has a collaboration agreement with the Mayo Clinic. Telo Genomics Corp. is headquartered in Toronto, Canada.

Compare TELO to Peers and Sector

Metrics to compare
TELO
Peers
Sector
Relationship
P/E Ratio
−1.7x−4.0x−0.5x
PEG Ratio
−0.10−0.090.00
Price/Book
−169.2x1.4x2.6x
Price / LTM Sales
-0.9x3.3x
Upside (Analyst Target)
-245.0%45.8%
Fair Value Upside
Unlock21.0%6.4%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 25, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Telo Genomics (TELO) Share Price Today?

The live Telo Genomics share price today is 0.0450

What Stock Exchange Does Telo Genomics (TELO) Trade On?

Telo Genomics is listed and trades on the TSX Venture Exchange.

What Is the Ticker (Stock Symbol) for Telo Genomics?

The stock symbol (also called a 'ticker') for Telo Genomics is "TELO."

What Is the Current Telo Genomics Market Cap?

As of today, Telo Genomics market capitalisation is 4.52M.

What Is Telo Genomics's (TELO) Earnings Per Share (TTM)?

The Telo Genomics EPS is currently -0.03 (Trailing Twelve Months).

Is TELO a Buy or Sell From a Technical Analyst Perspective?

Based on today's Telo Genomics moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Telo Genomics Stock Split?

Telo Genomics has split 2 times. (See the TELO stock split history page for full effective split date and price information.)

What is the current trading status of Telo Genomics (TELO)?

As of 08 Feb 2026, Telo Genomics (TELO) is trading at a price of 0.0450, with a previous close of 0.0450. The stock has fluctuated within a day range of 0.0450 to 0.0450, while its 52-week range spans from 0.0400 to 0.1400.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.